Loading…
Loading…
Mirum Pharmaceuticals, Inc. (Nasdaq: MIRM), a leading rare disease company, today announced new data from its rare liver disease programs. Late-breaking result
In this article, we explore the basics of buffer ETFs and share our thoughts on why we think these ETFs could be a powerful tool for managing risk. By selecting a buffer ETF with a predefined payoff profile that best matches one's preferences, one can achieve the equivalent of a customized option strategy to position for a pullback. The ideal scenario for using buffer ETFs would be when the market has performed exceptionally well and is at risk of a potential pullback.
Greetings, VettaFi Voices! In recent months, we've talked about a lot of different issues, from the micro to the macro, but let's go REALLY big picture this week.
No recent filings indexed.
Full call transcripts — prepared remarks + analyst Q&A — with speaker-by-speaker formatting and one-click switching across every quarter on file.
Click below to see what's inside, then upgrade to read every transcript for BSEP and 80,000+ other tickers.
Transcripts source: company-published earnings calls. Speaker attribution and formatting are processed in-app.